Clinical Trial Update: A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety of M207 for acute treatment of migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• M207

Snippet

Sponsor: Zosano Pharma Corporation | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2020-08-19